J.B. Chemicals & Pharmaceuticals Ltd. | Ownership
Companies that own J.B. Chemicals & Pharmaceuticals Ltd.
DSP BlackRock Investment Managers Pvt Ltd.
3,448,659
4.13%
1,003
0.28%
07/31/2018
Franklin Templeton Asset Management (India) Pvt Ltd.
2,981,497
3.57%
0
0.19%
07/31/2018
ICICI Prudential Asset Management Co. Ltd.
1,433,352
1.72%
-117,825
0.04%
08/31/2018
Dimensional Fund Advisors LP
1,038,906
1.24%
1,305
0%
04/30/2018
General Insurance Corp. of India (Invt Port)
751,000
0.9%
-150,000
0.08%
03/31/2017
Bellevue Asset Management AG
200,000
0.24%
200,000
0.01%
12/31/2017
Van Eck Associates Corp.
172,061
0.21%
0
0%
09/05/2018
BNY Mellon Asset Management North America Corp.
159,342
0.19%
2,104
0%
09/06/2018
Sundaram Asset Management Co. Ltd.
59,082
0.07%
0
0.01%
08/31/2018
Dimensional Fund Advisors Ltd.
51,663
0.06%
-3,224
0%
11/30/2017
| Address |
Neelam Centre, B Wing
Mumbai Maharashtra 400030
India
|
|
Employees
|
- |
| Website |
http://www.jbcpl.com |
| Updated |
07/08/2019 |
| JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. It operates through the following business units: India; Russia & CIS; Global; Contrast Media; API; and Business Development. The India business unit produces medicine for gastro, cardiac, and pain management. |
